• Am. J. Transplant. · Jul 2021

    Case Reports

    Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor.

    • Tommaso Maria Manzia, Carlo Gazia, Ilaria Lenci, Roberta Angelico, Luca Toti, Andrea Monaco, Alessandro Anselmo, Leonardo Baiocchi, Paolo Grossi, and Giuseppe Tisone.
    • Hepato-Pancreato-Biliary and Transplant Unit, University of Rome Tor Vergata, Rome, Italy.
    • Am. J. Transplant. 2021 Jul 1; 21 (7): 2600-2604.

    AbstractThe coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 currently affected more than 108 million people worldwide with a fatality rate of 2.2%. Herein, we report the first case of liver transplantation (LT) performed with a liver procured from a SARS-CoV-2 positive donor. The recipient was a 35-year-old SARS-CoV-2 positive female patient affected by severe end-stage HBV-HDV-related liver disease (model of end-stage liver disease = 32) who had neutralizing SARS-CoV-2 antibodies (titers 1:320) at time of LT. The LT was successful, and the graft is functioning two months after surgery. The recipient cleared the SARS-CoV-2 infection 1 month after LT. The current case shows that the prompt use of SARS-CoV-2 infected liver donors offers an invaluable life-saving opportunity for SARS-CoV-2 positive wait-listed patients who developed neutralizing SARS-CoV-2 antibodies.© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…